A type of prostate cell that has been largely ignored by cancer researchers can trigger malignant prostate cancer. The studies provide researchers with a new tool for exploring the genetic changes that lead to prostate cancer. The advance may help in developing new treatments for the disease, which causes some 32,000 deaths in the United States annually.